In addition, we performed genomic alteration analysis, prognosis analysis, gene set enrichment analysis (GSEA), immune cell infiltration analysis and drug sensitivity analysis based on SLC1A5 expression across cancers. This evidence concerns the gene SLC1A5 and cancer.